Measurements of chromogranins and chromogranin-related peptides by immunological methods

Advances in Experimental Medicine and Biology

Volumn 482, Issue , 2000, Pages 319-327

  Stridsberg, M ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN;

ASSAY; CONFERENCE PAPER; IMMUNOCYTOCHEMISTRY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RADIOIMMUNOASSAY;

ANIMALS; CHROMOGRANIN A; CHROMOGRANINS; HUMANS; IMMUNOASSAY; NEUROENDOCRINE TUMORS; PEPTIDE FRAGMENTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034471927     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (34)

1. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors
2. Immunoluminometric assay of chromogranin A in serum with commercially available reagents
3. Characterisation of circulating chromogranin A in human cancer patients
4. Immunostaining for vasostatin 1 distinguishes between ileal and lung carcinoids
5. A new human chromogranin A (CGA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)
6. Enzyme-linked immunosorbent assay for chromogranin A
7. A polyclonal antiserum against chromogranins A and B: A new sensitive marker for neuroendocrine tumors
8. Chromogranin A in uremia: Progressive retention of immunoreactive fragments
9. Chromogranin A in familial pheochromocytoma: Diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution
10. Different processing of chromogranin B into GAWK-immunoreactive fragments in the bovine adrenal medulla and pituitary gland
11. Production of chromogranin A and B derived peptides in human small cell lung carcinoma cell lines
12. Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
13. Library of sequence-specific radioimmunoassays for human chromogranin A
14. Highly sensitive enzyme immunoassay for bovine chromogranin A: Application for studies of regional distribution in bovine central nervous system
15. Secretoneurin: A neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)
16. Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues
17. PE-11, a peptide derived from chromogranin B, in the human brain
18. Pancreastatin-like immunoreactivity in human carcinoid disease
19. Simple enzyme immunoassay for the measurement of immunoreactive chromogranin A in human plasma, urine and saliva
20. Immunoreactive chromogranin A in rat plasma and urine measured by region-specific radioimmunoassay
21. Region-specific radioimmunoassay for human chromogranin A
22. A comparison between the diagnostic value of gonadotropins, α-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, α-subunit-secreting, and gonadotroph pituitary adenomas
23. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones
24. Secretion of chromogranin A by peptide-producing endocrine neoplasms
25. Rapid radioimmunoassay of circulating chromogranin A: In vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure
26. Serum gastrin and chromogranin A during meals
27. Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: Development of a specific radioimmunoassay for chromogranin A and its fragments
28. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours
29. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma
30. Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas
31. Neuroendocrine sources of chromogranin-A in normal man: Clues from selective stimulation of endocrine glands
32. Suppression of chromogranin A release from neuroendocrine sources in man: Pharmacological studies
33. Plasma pancreastatin-like immunoreactivity in various diseases
34. Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma